Purchase Order HT942524P0117
Award Date
8/26/24
Potential Completion Date
10/21/24
Potential Value
$81K
Federal Agency
Defense Health Agency
Awardee
Kilobaser Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94105, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $173,670 firm fixed price purchase order to Kilobaser Corporation for three Kilobaser One-XT Extended Edition benchtop synthesizers. Kilobaser Corp. will deliver the synthesizers to perform standard and advanced oligonucleotide synthesis, modifying deoxyribonucleic acid and ribonucleic acid. The place of performance will be Austria, and the period of performance is from August 2023 through September 2029. The synthesizers will support the Defense Health...
The Department of the Navy, Secretary of the Navy Office of Naval Research awarded a $51,390 firm fixed price purchase order to Kilobaser Corporation for a benchtop DNA and RNA synthesizer. The award stemmed from a March 2024 special notice posted on the Federal Business Opportunities website announcing the Navy's intent to award a sole source contract to Kilobaser to fulfill its requirements. No set-aside was used for this procurement. Performance will take place in Washington, D.C. and must be...
The U.S. Army Contracting Command Aberdeen Proving Ground has awarded a firm-fixed-price purchase order contract to Sierra Biosystems, Inc. for an Oligonucleotide Synthesizer. The contract, valued at $96,910.00, has an ultimate completion date of November 1, 2024. The place of performance is the Army Research Laboratory in Austin, Texas. This contract was awarded as a result of a sources sought notice to locate potential sources, particularly small businesses, that can meet the salient...
This firm fixed price contract was awarded by the Defense Health Agency to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned for-profit manufacturer of custom molecular biology and synthetic biology products. The $161,390 contract is for the delivery of MYBAITS-1-768-B DNA reagents to support the agency's biomedical research and casework by providing specialized genomic and diagnostic tools to develop new tests and treatments for service members. This contract is a...
The U.S. Army Medical Research Acquisition Activity (USAMRAA) awarded a sole source, firm fixed price contract worth $404,505.00 to DNA Script Inc., a foreign-owned, for-profit business, to provide a benchtop DNA synthesizer and four-year maintenance plan. The synthesizer will support targeted pathogen discovery efforts at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). DNA Script Inc. is the sole source provider of this specialized equipment, which can...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to DNASTAR, Inc., a for-profit Subchapter S corporation, for a Lasergene Genomics Suite site license. The contract has a ceiling value of $107,500.00 and a period of performance through August 27, 2025. The contract was awarded as a sole-source acquisition under FAR 13.106-1(b)(1)(i) as DNASTAR is the sole developer, manufacturer, and distributor of the Lasergene Genomics Suite software, which is required...
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of customized solutions for molecular biology and synthetic biology projects. The contract is a call under a $5.3 million single-award blanket purchase agreement (BPA) with DHA to supply custom DNA reagents and MYBAITS reagents through September 2027. The specific contract is for the delivery of 5 units of...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned, for-profit organization that specializes in DNA synthesis solutions. The contract, valued at $56,000.00, is for the maintenance of Biolytic's DR. OLIGO 48 DNA synthesizers. The contract has a completion date of February 9, 2026. Biolytic Lab Performance Inc. has extensive experience providing DNA synthesizers, related instruments,...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the maintenance of a medium throughput DNA synthesizer and related reagents. The contract, valued at $54,000.00, has an ultimate completion date of September 25, 2025. Biolytic Lab Performance Inc. is the prime contractor, and there is no set-aside designation for this award. The company has a proven track...
This is a firm-fixed-price contract awarded by the Defense Health Agency (DHA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned for-profit manufacturer of specialized genomic and proteomic research tools. The contract, valued at $368,160.00, is for the delivery of MYBAITS custom reagents and other consumables over a period ending on July 26, 2024. This is a call against a larger $5.3 million Blanket Purchase Agreement (BPA) that Biodiscovery LLC holds with DHA,...